Oppenheimer Downgrades Endo Pharmaceuticals Holdings Inc (ENDP) to Perform
- Wall Street stocks fall as weak GDP growth spreads rate-cut gloom
- Q1 US GDP shows surprise slowing and uncomfortable inflation
- Alphabet (GOOGL) soars 16% on Q1 results beat, first-ever dividend
- Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans
- Oil settles higher as weak U.S. economic growth offset by supply concerns
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hasbro (HAS) brand strength sees earnings top expectations
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- After-hours movers: Alphabet, Microsoft, Snap, Intel, and more
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
Endo Pharma (ENDP) Possibly in Talks to Sell Itself - Reuters
January 30, 2013 2:41 PM ESTEndo Pharmaceuticals Holdings (NASDAQ: ENDP) is ripping higher today as Reuters says the pharma might be in talks to sell itself. The stock is now up over 10 percent on the session.
Interested parties include Warner Chilcott (Nasdaq:... More
UPDATE: Endo Pharma (ENDP) shares paused for volatility
January 30, 2013 2:29 PM EST(Updated - January 30, 2013 2:34 PM EST)
Endo Pharmaceuticals Holdings (NASDAQ: ENDP) shares paused for volatility.
UPDATE - Market chatter has Endo potentially being in talks for a sale, though nothing has been confirmed. Shares were up about 9.5 percent at the pause.... More